We have utilized CD23 expression as a marker for B cell activation in order to investigate the biochemical basis for synergy between antigen and T helper (Th) cells 
Introduction
Antigen binding to surface immunoglobulin (slg) on resting murine and human B cells stimulates the rapid turnover of membrane inositol lipids (1) (2) (3) . Inositol lipid hydrolysis results in the formation of two "second messenger" molecules, which link receptor-ligand interactions with cellular responses in a wide variety of cell types: inositol 1,4,5 trisphosphate (1P3),' 1 . Abbreviations used in this paper: AFC, antibody forming cells; BCGF, B cell growth factor, [Ca2+] ,, intracellular free calcium concentration; DG, diacylglycerol; DiC8, dioctanoyl 1,2 diacylglycerol; EN, which causes a rise in intracellular free Ca2" concentration ([Ca2+] i), and diacylglycerol (DG) which serves as a cofactor in the activation of protein kinase C (PKC) (4) (5) (6) (7) . Functionally, antigen-induced B cell activation serves as a proliferative stimulus and readies the B cell to respond to T cell help (8, 9) . In contrast to this rather well characterized sequence of antigendependent events, neither the biochemical basis of Th cell induced B cell activation nor the mechanism by which antigen and Th cells synergize in B cell activation have been elucidated.
In previous studies, we employed cloned, IL-2 dependent, allospecific human Th cells to investigate the early events in human B cell activation. We reported that within 8-16 hours of major histocompatibility (MHC) specific interaction between allospecific Th cells and allogeneic B cells, a significant fraction of the B cell pool is induced to express a B cell/monocyte lineage restricted activation antigen, CD23 (10). The unique capacity of the Th cell-derived lymphokine, IL-4, to trigger CD23 expression, coupled with the requirement for close physical contact between antigen-activated Th cells and responder B cells for optimal CD23 expression led us to suggest that Th cells may release IL-4 locally at the site of Th cell-B cell interaction ( 11) . In this regard, evidence for site directed exocytosis of IL-4 by murine Th cells has been described ( 12) .
We recently reported that Th cell-induced CD23 expression by resting human B cells occurs in the absence of enhanced B cell inositol lipid metabolism or a rise in B cell [Ca2+] , (13) .
Conversely, ligation of sIg receptors on resting human B cells triggers inositol lipid hydrolysis but does not lead to CD23 expression (13) . Of interest, while Th-B cell interaction does not affect the changes in B cell inositol lipid metabolism or
[Ca2+]i induced by sIg crosslinking (13) , Defrance et al. have shown that sIg receptor crosslinking enhances CD23 expression induced by rIL-4 (14) . These data suggest that the synergistic effects of antigen and Th cell signaling on B cell activation may occur at a point(s) distal to B cell inositol lipid hydrolysis and associated "second messenger" generation, and that the CD23 induction assay can be utilized to explore the biochemical basis for this synergy. The experiments described here address this possibility.
Methods
Reagents. rIL-4 was obtained from Genzyme (Boston, MA) and was reconstituted at a concentration of 10,000 U/ml. The monoclonal anti-human IgM antibodies, Mu53, P24, HB57, and 5D7 were generously provided by Dr Preparation oftarget B cell populations. Human peripheral blood or tonsil mononuclear cells were isolated on Ficoll-Hypaque density gradients. T and non-T cells were separated on Ficoll-Hypaque density gradients after rosetting the T cells with neuraminidase-treated sheep red blood cells (EN), as previously described (17) . Non-T cells were suspended at 2 X 106 cells/ml in RPMI 1640 (Gibco Laboratories, Grand Island, NY) containing 10% fetal calf serum (Hazelton-Dutchland, Inc., Denver, PA), penicillin and streptomycin 50 U/ml (Gibco Laboratories, Grand Island, NY), 2 mM glutamine (Gibco), "culture medium," and incubated in a horizontally placed plastic tissue culture flask (3024; Falcon Labware, Oxnard, CA) at 370C, 5% CO2 for 16 h to remove adherent cells. In some experiments, tonsil nonadherent, non-T cells were enriched for high density (resting) and low density (preactivated) B cell populations on discontinuous Percoll gradients as previously described (18) . A typical high density B cell population (Percoll fraction 4, Table I ) isolated in this manner contained > 98% sIg, < 1% CD3, < 1% MO2, 9% 4F2, and 64% sIgD positive cells. The low density B cells (Percoll fraction 1, Table I) were > 98% sIg, < 1% CD3, < 1% MO2, 47% 4F2, and 46% sIgD positive cells.
T cell clones. The IL-2 dependent human Th clones employed in these studies have been described previously. Allospecific Th clones include clone A-7, DR3 reactive (19); clone A-57, DR2 reactive (19) ; and clone 86, DRl reactive (20) . All of these Th clones are CD3 positive, CD4 positive, and CD8 negative, and proliferate in a MHC-restricted manner to allogeneic stimulator cells expressing the relevant MHC class II antigen. In addition, both clone A-57 and A-7 have been shown to provide MHC restricted helper activity for allogeneic B cells as measured by the induction of B cell proliferation and differentiation into antibody forming cells (AFC) (19) .
CD23 induction assay. The induction of CD23 by cloned Th cells has been described previously (10). Briefly, 5 X 105 B cells were incubated at 37°C in final medium alone or in the presence of 1 Maximal CD23 expression requires the continued presence of both rIL-4 and a PKC activator. During an immune response, antigen specific Th-B cell interactions are dependent on, and occur subsequent to, antigen binding and processing by the B cell. It is, therefore, logical to postulate that PKC activation, induced by antigen binding, may "prime" the B cell to respond more effectively to a subsequent interaction with Th cell derived IL-4. Fig. 8 depicts a representative experiment that examines the effect ofvarying the sequence of B cell interaction with these two classes of stimuli. In this experiment, B cells were precultured for 12 h with medium, the water soluble PKC activating phorbol PDB, or rIL-4. The B cells were then washed, treated as indicated in secondary culture for an additional 16 h, and assayed for CD23 expression. As shown, overnight preincubation with rIL-4 triggers CD23 expression, but this response is not enhanced by subsequent exposure to PDB. In contrast, exposure to PDB during the overnight preculture period primes the B cell to respond more efficiently to rIL-4, as assessed by an increase in the percent of Analogous studies involving short term (a few hours) preculture provided several important, but essentially negative pieces of data (results not shown). In particular, rIL-4 induced CD23 expression requires prolonged exposure to the lymphokine. Treatment of B cells with rIL-4 for a few hours, followed by washing and overnight culture in medium alone, does not trigger a CD23 response. In addition, short term exposure to a PKC activator, or the combination a PKC activator and rIL-4, does not lead to CD23 expression, nor is it sufficient to enhance CD23 expression triggered by the presence of rIL-4 during secondary culture. We would point out, that in these experiments synergy in CD23 expression is observed if both rIL-4 and a PKC activator are present during the secondary culture period.
Taken together, these studies emphasize the importance, of both the sequence and duration of B cell interaction with both classes of activating stimuli. In particular, they suggest that optimal B cell activation requires prolonged exposure to both a PKC activating signal and IL-4, and that PKC activation may occur before, concomitant with, but not after IL-4 signaling.
Discussion
While it is well established that antigen and Th cells play crucial roles in the process of B cell activation, the biochemical events which these signals initiate within the B cell are only beginning to be defined. In this report, we have utilized the CD23 expression assay in order to examine the biochemical basis for the synergistic effects of antigen and Th cell signaling on human B cell activation.
Our results confirm that sIg crosslinking, mediated by the antigen analogues F(ab')2 goat anti-human IgM and monoclonal murine anti-human IgM antibody, enhances CD23 expression induced by either rIL-4 or antigen specific Th-B cell interaction. Utilizing a panel of monoclonal anti-human 1gM antibodies, well characterized with respect to specificity, affinity, and function, we observed a positive correlation between the capacity of a particular monoclonal antibody to synergize with rIL-4 in the CD23 expression assay and with BCGF in the induction of B cell proliferation (15, 16 lymphokines (e.g., IL-4) is also crucial to optimal B cell activation.
It should be emphasized that the activation of resting B lymphocytes is a complex process that involves both cell division and differentiation into antibody secreting cells. Moreover, the antigen analogues that we have employed in these studies, anti-IgM antibodies, are known to differentially regulate these events; enhancing proliferative responses while profoundly inhibiting differentiation (22, 23) . While the relationship between these in vitro effects and the in vivo process of B cell tolerance are speculative, it is of obvious importance to evaluate the functional potential of human B cells relative to their surface expression of the CD23 molecule. Our data suggest that these studies can be approached using cloned allospecific Th cells, which provide MHC restricted "help" for both B cell proliferation and differentiation, in concert with biochemical analogues of the second messenger molecules generated during inositol lipid hydrolysis.
Finally, while the biochemical pathways that Th cells and IL-4 activate in the B cell have not been defined, it is clear that inositol lipid hydrolysis and increased B cell [Ca2+ji are not involved (13, 24) . Thus, while antigen analogues and rIL-4 act in concert to enhance CD23 expression, these two classes of B cell activators presumably generate distinct sets of "second messenger" molecules in the B cell. As optimal CD23 responses are induced when PKC activation occurs prior to or concomitant with the rIL-4 signal, one explanation for our data is that the PKC dependent phosphorylation of a cellular target of IL-4 enhances the rate of CD23 gene transcription, the stability of CD23 mRNA transcripts, the efficiency of translation, or steps involved in posttranslational modification. The availability of cDNA probes for CD23 should allow this issue to be explored (25) .
